- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials Sponsored by Suzhou Kanova Biopharmaceutical Co., LTD
Total 874 results
-
Innovent Biologics (Suzhou) Co. Ltd.Not yet recruitingDiffuse Large B-Cell Lymphoma
-
Suzhou Genhouse Bio Co., Ltd.RecruitingColorectal Cancer | Pancreatic Cancer | Non-small-cell Lung Cancer | Advanced Solid Tumor | Head and Neck TumorChina
-
Innovent Biologics (Suzhou) Co. Ltd.Not yet recruiting
-
Suzhou Junjing BioSciences Co., Ltd.Recruiting
-
Coherent Biopharma (Suzhou) Co., Ltd.Recruiting
-
Innovent Biologics (Suzhou) Co. Ltd.Recruiting
-
Coherent Biopharma (Suzhou) Co., Ltd.Recruiting
-
Innovent Biologics (Suzhou) Co. Ltd.Recruiting
-
Innovent Biologics (Suzhou) Co. Ltd.CompletedIndolent Non-hodgkin LymphomaChina
-
Innovent Biologics (Suzhou) Co. Ltd.Completed
-
Innovent Biologics (Suzhou) Co. Ltd.Completed
-
Suzhou Genhouse Bio Co., Ltd.Active, not recruitingAdvAdvanced Solid Tumors | Kirsten Rat SarcomaChina
-
Suzhou Abogen Biosciences Co., Ltd.Active, not recruitingCOVID-19Philippines, Pakistan, United Arab Emirates, Indonesia
-
Innovent Biologics (Suzhou) Co. Ltd.Completed
-
Innovent Biologics (Suzhou) Co. Ltd.Completed
-
Innovent Biologics (Suzhou) Co. Ltd.Terminated
-
Innovent Biologics (Suzhou) Co. Ltd.Completed
-
Suzhou Transcenta Therapeutics Co., Ltd.Completed
-
Innovent Biologics (Suzhou) Co. Ltd.Active, not recruiting
-
Innovent Biologics (Suzhou) Co. Ltd.CompletedAdvanced Solid TumorChina
-
Innovent Biologics (Suzhou) Co. Ltd.Completed
-
Innovent Biologics (Suzhou) Co. Ltd.Suspended
-
Suzhou Transcenta Therapeutics Co., Ltd.TerminatedLocally Advanced or Metastatic Cancers | Metastatic Human Papillomavirus-Related Malignant NeoplasmUnited States
-
Innovent Biologics (Suzhou) Co. Ltd.Completed
-
Innovent Biologics (Suzhou) Co. Ltd.CompletedAdvanced Malignant Tumors LymphomasUnited States
-
Innovent Biologics (Suzhou) Co. Ltd.Completed
-
Innovent Biologics (Suzhou) Co. Ltd.CompletedHomozygous Familial HypercholesterolemiaChina
-
Innovent Biologics (Suzhou) Co. Ltd.CompletedCLDN18.2 Positive Solid TumorsChina
-
Innovent Biologics (Suzhou) Co. Ltd.TerminatedAdvanced Cutaneous Squamous Cell CarcinomaChina
-
Innovent Biologics (Suzhou) Co. Ltd.TerminatedA Study of Sintilimab Plus Ramucirumab as First-line Treatment for G/EGJ Adenocarcinoma (ORIENT-106)Gastric AdenocarcinomaChina
-
Innovent Biologics (Suzhou) Co. Ltd.CompletedAdvanced Solid TumorsChina
-
Innovent Biologics (Suzhou) Co. Ltd.Completed
-
Innovent Biologics (Suzhou) Co. Ltd.CompletedAdvanced Solid TumorsChina
-
Innovent Biologics (Suzhou) Co. Ltd.Completed
-
Suzhou Abogen Biosciences Co., Ltd.Active, not recruiting
-
Innovent Biologics (Suzhou) Co. Ltd.CompletedCancer, Solid TumorChina
-
Innovent Biologics (Suzhou) Co. Ltd.Active, not recruitingAdvanced Malignant TumorsChina
-
Innovent Biologics (Suzhou) Co. Ltd.Active, not recruitingAdvanced Hepatocellular CarcinomaChina
-
Innovent Biologics (Suzhou) Co. Ltd.Active, not recruiting
-
Innovent Biologics (Suzhou) Co. Ltd.CompletedHealthy Male SubjectsChina
-
Innovent Biologics (Suzhou) Co. Ltd.Completed
-
Innovent Biologics (Suzhou) Co. Ltd.CompletedAdvanced/Metastatic Solid MalignanciesUnited States
-
Innovent Biologics (Suzhou) Co. Ltd.CompletedEsophageal Squamous Cell CarcinomaChina
-
Innovent Biologics (Suzhou) Co. Ltd.CompletedHypercholesterolemiaChina
-
Innovent Biologics (Suzhou) Co. Ltd.Completed
-
Innovent Biologics (Suzhou) Co. Ltd.UnknownNeovascular Age-related Macular DegenerationChina
-
Suzhou MicroPort OrthoRecon Co. LTDCompleted
-
Innovent Biologics (Suzhou) Co. Ltd.Completed
-
Sumitomo Pharma (Suzhou) Co., Ltd.Completed
-
Sumitomo Pharma (Suzhou) Co., Ltd.Completed